Cold & Cough Remedies (Pharmacies) - Niger

Revenue in the Cold & Cough Remedies market is projected to reach US$4.19m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.99%, resulting in a market volume of US$5.61m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$0.15 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Niger has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences: In Niger, customers have shown a growing preference for over-the-counter cold and cough remedies available in pharmacies. This is due to the convenience and accessibility of these products, as well as the trust placed in the expertise of pharmacists. Customers value the ability to quickly and easily purchase these remedies without the need for a prescription.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Niger is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the potential side effects of traditional medications and are seeking alternative options. This trend is driven by a desire for more holistic and sustainable healthcare solutions. Another trend in the market is the rising demand for combination cold and cough remedies. Customers are looking for products that can address multiple symptoms at once, such as congestion, coughing, and sore throat. This trend is driven by the need for convenience and cost-effectiveness.

Local special circumstances: Niger is a country with a high prevalence of respiratory diseases, such as asthma and bronchitis. This has contributed to the increased demand for cold and cough remedies in the country. Additionally, the country experiences a dry and dusty climate, which can exacerbate respiratory symptoms and lead to a higher demand for remedies.

Underlying macroeconomic factors: The economic growth in Niger has led to an increase in disposable income among the population. As a result, more people are able to afford healthcare products, including cold and cough remedies. This has contributed to the growth of the market. Furthermore, the government of Niger has implemented policies to improve access to healthcare services, including the availability of medications in pharmacies. This has created a favorable environment for the growth of the Cold & Cough Remedies (Pharmacies) market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Niger is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination products, the local prevalence of respiratory diseases, and the country's economic growth and government policies. These factors have created a favorable market environment for the growth of the industry.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.